Friday, 21 July 2023
The ÌÇÐÄÔ´´ was host to the first, annual Advanced Pain Discovery Platform (APDP) conference, bringing together UK research resources and expertise with people who suffer with chronic pain, to discuss a problem that affects so many lives.
APDP has been supported by £25m in grant funding from UK Research & Innovation, Versus Arthritis, Eli Lilly, the Medical Research Foundation, and additional diverse funding sources. The conference demonstrated how the APDP is leading the world in pain research through its consortia, data hub, research projects, and strong international links.
The APDP conference welcomed 200 delegates: hosting a network of researchers from universities across the UK, pharmaceutical companies, people with lived experience of pain, charities, and government sectors.
The topic of pain is becoming visible in the UK – it is being discussed openly and more often in forums like this, and people who experience pain no longer must suffer in silence.
APDP encompasses the research from across the UK with the ÌÇÐÄÔ´´ as a central element of this network. APDP delegates presented new and exciting pain research projects for the first time and revealed how biology, psychology and society determine the pain that people suffer, pointing the way to new treatments for the future. The conference was organised and delivered by multidisciplinary team of researchers working hand in hand with members of public.
David Walsh, Professor of Rheumatology at the ÌÇÐÄÔ´´ and Programme Director of the APDP, comments: “This conference has highlighted how much progress has been made towards improving the lives of people with chronic pain. The UK has world-leading expertise and resources. The topic of pain is becoming visible in the UK – it is being discussed openly and more often in forums like this, and people who experience pain no longer must suffer in silence”.
The pivotal influence on APDP research from people with lived experience of pain was illustrated at the conference by research from Newcastle University, the University of Bristol and the University of Dundee. Conference demonstrations proved the working principle of a pioneering portable device, which will allow chemotherapy patients to test whether their nerves are being damaged by their cancer treatment
Antony Chuter, a member from the patient and public involvement group, added: "It was fantastic to see how people like me with pain have changed pain research in the UK and to be an equal partner in this conference.”
The UK is at the forefront of pain research and this year’s first national conference set the blueprint for the future scientific advances. The APDP’s collaborative network is finding synergies, removing barriers and showing that by working together, we can answer the challenges posed by chronic pain.
Story credits
More information is available from David Walsh, Professor of Rheumatology at the ÌÇÐÄÔ´´ at david.walsh@nottingham.ac.uk
Adam Mallaby - Media Relations Manager for the Faculty of Medicine and Health Sciences (Maternity Cover)
Email: adam.mallaby@nottingham.ac.uk
Phone: 0115 748 5719
Location:
Notes to editors:
About the ÌÇÐÄÔ´´
Ranked among the world's top 100 universities , the ÌÇÐÄÔ´´ delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what’s next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the ÌÇÐÄÔ´´ invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we’re creating knowledge, opportunity and solutions that help change what's next.